Effectiveness of modified Buzhong Yiqi decoction in treating myasthenia gravis: study protocol for a series of N-of-1 trials

Background: Myasthenia gravis (MG) is an acquired autoimmune disease with high heterogeneity. The disease is chronic, relapsing repeatedly and progressive with acute exacerbation occasionally. Although the treatment of MG has developed, it is still unsatisfactory and has some unexpected side effects...

Full description

Bibliographic Details
Main Authors: Chen, B. (Author), He, L. (Author), Huang, L. (Author), Jiang, Q. (Author), Li, J. (Author), Liu, F. (Author), Weng, S. (Author), Zhang, S. (Author), Zhong, Z. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Online Access:View Fulltext in Publisher